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showed average of 64.94 ± 0.84 mGy and 37.64 ± 1.20 mGy in 
left ovary part and average of 64.38 ± 1.85 mGy and 32.96 ± 
1.11 mGy in right ovary part. This showed when executing 
Tomotherapy, measured scattered dose of Tomo Helical 
method which has relatively greater monitor units (MUs) and 
longer irradiation time are approximately 1.8 times higher 
than Tomo direct method. 
Conclusions: Scattered dose of left and right ovary of 
childbearing women is lower than ICRP recommended does 
which is not seriously worried level against the infertility and 
secondary cancer occurrence. However, as breast cancer 
occurrence ages become younger in the future and radiation 
therapy using high-precision image guidance equipment like 
Tomotherapy is developed, clinical follow-up studies about 
the ovary dose of childbearing women patients would be 
more required.  
   
EP-1639   
Dosimetric comparison of techniques and impact of 
displacements in lower limb sarcoma radiation therapy 
M. Arthurs1, C. Gillham2, E. O’Shea2, E. McCrickard2, M. 
Leech1 
1Applied Radiation Therapy Trinity Research Group, 
Discipline of Radiation Therapy School of Medicine Trinity 
College Dublin, Dublin, Ireland Republic of  
2St. Luke’s Radiation Oncology Network, Radiotherapy 
Department, Dublin, Ireland Republic of  
 
Purpose/Objective: Radiation therapy (RT) is frequently used 
as an adjunctive treatment for soft tissue sarcoma of the 
lower limb. RT carries a risk of long term side effects 
including limb fibrosis, joint stiffness, lymphoedema and 
bone fractures. This study compared dosimetric data 
between 3DCRT and IMRT plans in a population of lower limb 
sarcoma patients immobilised with an in-house device and 
quantified the impact of systematic and random errors on 
these techniques. The dosimetric effect of translational 
displacements on target coverage and organs at risk (OARs) 
were considered. 
Materials and Methods: Eleven anonymised patients’ CT data 
were acquired. Patients had previously been treated with 
postoperative radiotherapy. A 3DCRT and IMRT plan was 
created for each patient. Total doses ranged from 60-66 Gy, 
prescribed at 2 Gy per fraction. The techniques were 
dosimetrically compared. Population-based systematic errors 
were applied to 3 fractions of each 3DCRT and IMRT plan. 
Population-based random errors were applied to 5 fractions 
of each 3DCRT and IMRT plan. The dose metrics were 
analysed and the results were compared to the initial plans. 
Results: Higher target D95, D2, D98, D50 and the best 
homogeneity index resulted with IMRT compared to 3DCRT 
(p<0.01). Maximum bone dose was higher in IMRT than 3DCRT 
(p<0.0001). Systematic errors increased target D2 in IMRT 
(p<0.05). Random errors decreased target homogeneity in 
IMRT (p<0.05), decreased mean dose to bone in both 3DCRT 
and IMRT, and decreased bone V40 in 3DCRT. Neither random 
nor systematic errors increased OAR dose for IMRT or 3DCRT 
plans.  
 
 
 
Conclusions: IMRT could become the favoured lower limb 
sarcoma radiation therapy technique due to superior target 
coverage and homogeneity. However, higher bone Dmax seen 
with IMRT compared to 3DCRT potentially increases the risk 
of late bone toxicity. Offline imaging can adequately correct 
for systematic translational errors in these patients when an 
in-house immobilisation device is used. Results would 
indicate that to maintain target homogeneity in IMRT, daily 
online imaging would be required to reduce the effects of 
random displacements as well as quantifying daily rotations. 
Rotational displacements should be simulated in further 
study, as rotations may potentially have a further dosimetric 
effect on target coverage and OARs if not corrected for.  
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Purpose/Objective: Pre-treatment verifications of IMRT 
treatments are routinely performed by measuring the 
absorbed dose at a representative point in a water-
equivalent phantom using an ionization chamber. We 
evaluated the added value of performing entrance dose in 
vivo dosimetry (IVD) using diodes in breast treatments 
delivered using a SIB-IMRT technique. 
Materials and Methods: We studied 14 breast treatments 
delivered by a Clinac 2100C/D using a 6MV photon beam SIB-
IMRT technique and the RPM system (Varian) for respiratory 
motion management. For pre-treatment verifications, we 
recorded ionization chamber measurements and treatment 
planning system calculations (Eclipse; Varian) both for per-
beam and integral dose at the measurement point. We also 
measured the time it took to perform the verifications. For 
each radiation field, the physicist selected 2 representative 
points at high and/or homogeneous fluence regions. We 
recorded the coordinates of these points and corresponding 
calculated entrance doses. Entrance dose IVD was performed 
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by placing 2 QED diodes (Sun Nuclear) on the patients’ skin at 
the aforementioned points. To ensure accurate positioning, 
we attached a template to the linac collimator using an add-
on. This template, by means of the light field, projected a 1 
cm square grid (at isocenter) on the patients’ skin (figure 
1a). We compared in vivo measurements collected by DPDpc 
(IBA) to entrance doses calculated by Eclipse. We repeated 
this process for each radiation field except those whose light 
field was shaded by the treatment couch. We also recorded 
the additional time taken to perform IVD measurements. 
Results 
 
 
 
 
 
Figure 1b shows the differences between per beam 
measurements and calculations both for pre-treatment 
verifications and IVD measurements. 
Table 1 compares pre-treatment verifications and IVD 
measurements in terms of: (a) per beam accuracy, defined as 
the 95th percentile of differences between individual 
measurements and calculations; (b) per patient accuracy, 
defined as the standard deviation of: differences between 
measured and calculated integral doses for pre-treatment 
verifications; and averages of all differences between diode 
readings and entrance doses for IVD; (c) speed, defined as 
the additional time required per patient; (d) exhaustiveness, 
defined as the percentage of radiation fields that provide 
significant dose contributions at measurement points (>0.05 
and >0.2 Gy for ionization chamber and diodes respectively). 
Conclusions: IVD using diodes presents larger uncertainties 
than pre-treatment verifications using ionization chambers. 
Two diodes per field are needed to minimize uncertainty to 
acceptable levels. However, IVD assesses more radiation 
fields than pre-treatment verifications based on one-point 
measurements fixing the same dose threshold, and is globally 
more time efficient. This work was funded by a grant from 
the Barcelona Board of the Spanish Association Against 
Cancer (AECC) 2012. 
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Purpose/Objective: We should reduce rectum dose for side 
effects in Radiation therapy. We have developed a dummy 
structure in PTV .We have carry out this method in clnical 
data alredy.The overall aim of the study was to reduce high 
dose in rectum at the prostate cancer therapy in Helical 
therapy at Tomotherapy system. As many authors have 
reported that rectal hemorrhage important factor in high 
dose in rectum. We have come to expect good results. 
Materials and Methods: As first. We experimentally 
compared optimizing of using a dummy structure to no 
dummy structure. Dummy structures size were 
3mm,5mm,7mm,9mm. The fundamental study, it's were 
assessed using DVH(Dose volume histogram,76Gy,75Gy, 
70Gy,60Gy,50Gy,40Gy,30Gy) that was rectum dose in water 
equivalent phantom. and Structures of PTV ,Prostate,bladder 
and rectum from TG119(AAPM Task group 119) were used for 
the experiments and then these were optimized each of 10 
times using TPS(planning station).The systems used in this 
experiment were discussed below. As a next step.We 
performed a retrospective cohort study of patients with 
prostate cancer. The subjects of the present study are 10 
patients that we experienced in our department between 
May 2014 and September 2014.We used as a control 
simulation Data of each patients without dummy structure in 
PTV. 
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